Sichuan Kelun Pharmaceutical Co Ltd
SZSE:002422

Watchlist Manager
Sichuan Kelun Pharmaceutical Co Ltd Logo
Sichuan Kelun Pharmaceutical Co Ltd
SZSE:002422
Watchlist
Price: 30.6 CNY -7.66% Market Closed
Market Cap: 46.9B CNY
Have any thoughts about
Sichuan Kelun Pharmaceutical Co Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
Sichuan Kelun Pharmaceutical Co Ltd

Current Assets 18.9B
Cash & Short-Term Investments 7.7B
Receivables 7.5B
Other Current Assets 3.7B
Non-Current Assets 19.1B
Long-Term Investments 4.1B
PP&E 13.2B
Intangibles 1.3B
Other Non-Current Assets 456.1m
Current Liabilities 9.6B
Accounts Payable 2.3B
Accrued Liabilities 307.5m
Short-Term Debt 4.1B
Other Current Liabilities 2.9B
Non-Current Liabilities 6.1B
Long-Term Debt 1.9B
Other Non-Current Liabilities 4.2B

Balance Sheet
Sichuan Kelun Pharmaceutical Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
2 029
1 851
1 228
1 194
1 807
2 194
2 758
2 800
4 729
4 588
Cash
2
2
1
1
2
1
1
2 800
4 729
4 566
Cash Equivalents
2 027
1 849
1 227
1 193
1 805
2 193
2 757
0
0
23
Short-Term Investments
0
0
0
0
0
0
265
360
448
2 270
Total Receivables
4 340
4 593
4 974
6 951
7 124
8 077
7 762
6 922
7 454
7 037
Accounts Receivables
2 623
2 671
3 559
4 862
5 679
6 481
5 679
5 301
5 696
4 683
Other Receivables
1 717
1 922
1 415
2 089
1 445
1 596
2 083
1 622
1 758
2 354
Inventory
2 073
2 207
2 133
2 500
2 973
3 386
3 468
3 363
3 214
3 840
Other Current Assets
261
502
412
973
720
518
447
564
802
555
Total Current Assets
8 704
9 153
8 748
11 619
12 622
14 174
14 700
14 009
16 648
18 290
PP&E Net
10 672
11 571
12 027
12 452
12 399
12 428
12 318
11 965
11 331
12 379
PP&E Gross
10 672
11 571
12 027
12 452
12 399
12 428
12 318
11 965
0
12 379
Accumulated Depreciation
1 357
1 855
2 405
3 233
3 949
4 877
5 860
6 765
0
8 754
Intangible Assets
1 112
1 228
1 282
1 383
1 485
1 481
1 457
1 381
1 359
1 297
Goodwill
157
157
158
158
158
158
158
99
99
99
Long-Term Investments
455
342
988
2 138
2 306
2 762
2 751
3 409
3 811
3 992
Other Long-Term Assets
102
132
207
239
390
481
599
677
958
399
Other Assets
157
157
158
158
158
158
158
99
99
99
Total Assets
21 203
N/A
22 583
+7%
23 410
+4%
27 988
+20%
29 361
+5%
31 485
+7%
31 983
+2%
31 540
-1%
34 206
+8%
36 455
+7%
Liabilities
Accounts Payable
1 642
1 467
1 358
1 387
1 537
1 655
1 606
1 794
2 007
2 164
Accrued Liabilities
208
206
232
403
354
378
385
308
254
421
Short-Term Debt
1 992
4 809
4 818
6 718
4 862
4 394
5 317
5 540
3 528
3 831
Current Portion of Long-Term Debt
50
922
3 278
1 182
815
5 084
2 084
3 141
2 030
780
Other Current Liabilities
1 763
298
512
2 202
2 804
3 309
2 865
2 624
4 286
2 797
Total Current Liabilities
5 654
7 701
10 198
11 892
10 372
14 820
12 258
13 408
12 104
9 993
Long-Term Debt
3 735
3 416
1 386
3 496
5 449
2 147
5 100
3 522
4 756
2 894
Deferred Income Tax
84
74
72
243
221
248
261
254
266
264
Minority Interest
231
104
136
179
201
718
504
273
1 137
3 343
Other Liabilities
760
229
287
375
354
364
362
226
209
288
Total Liabilities
10 463
N/A
11 523
+10%
12 080
+5%
16 185
+34%
16 597
+3%
18 297
+10%
18 484
+1%
17 683
-4%
18 472
+4%
16 783
-9%
Equity
Common Stock
720
1 440
1 440
1 440
1 440
1 440
1 439
1 425
1 422
1 499
Retained Earnings
5 515
5 981
6 366
6 914
7 826
8 448
8 675
9 328
10 416
11 976
Additional Paid In Capital
4 415
3 675
3 477
3 532
3 550
3 549
3 889
3 581
3 673
6 144
Unrealized Security Profit/Loss
0
0
0
0
0
0
0
0
0
1
Treasury Stock
0
0
52
84
141
380
500
400
237
215
Other Equity
89
35
98
0
88
131
4
77
460
268
Total Equity
10 739
N/A
11 060
+3%
11 330
+2%
11 803
+4%
12 763
+8%
13 188
+3%
13 499
+2%
13 857
+3%
15 734
+14%
19 672
+25%
Total Liabilities & Equity
21 203
N/A
22 583
+7%
23 410
+4%
27 988
+20%
29 361
+5%
31 485
+7%
31 983
+2%
31 540
-1%
34 206
+8%
36 455
+7%
Shares Outstanding
Common Shares Outstanding
1 440
1 440
1 433
1 440
1 440
1 440
1 439
1 425
1 414
1 493

See Also

Discover More